You're currently viewing an old version of this dataset. To see the current version, click here.

Malawi Integrated HIV Program Report 2013 Q2

This is the 8th quarterly HIV Program report after implementation of the 2011 Integrated Clinical HIV Guidelines in July 2011. A summary of the key achievements between April and June 2013 is provided below:

  • Scale-up of integrated HIV services had reached the following number of sites:

    • 825 static (607 within and 218 outside of health facilities) and 534 outreach HTC sites

    • 671 (static) ART sites

    • 588 PMTCT sites (Option B+)

    • 623 Pre-ART sites

    • 603 sites with HIV-exposed child follow-up

  • 462,334 persons were tested and counselled for HIV and 37,852 (8%) were HIV positive; 156,875 (34%) people tested for the first time.

  • 16,763 (98%) of 17,142 blood units collected were screened for HIV, hepatitis B and syphilis.

  • 113,061 (77%) of 147,586 women at ANC had their HIV status ascertained; 9,282 (8%) of these were HIV positive. 108,861 (92%) of 118,402 women at maternity had their HIV status ascertained; 8,285 (8%) of these were HIV positive.

  • 26,802 patients started ART during this quarter; this is similar to the previous quarter (26,881).

  • 443,221 patients were alive and on ART by end of June 2013. This is equivalent to 74% coverage of the estimated 602,000 population in need of ART (all ages; 2013 Spectrum estimates based on current definition of eligibility for ART in Malawi).

  • 105,326 (26%) of 408,013 on first line adult regimens were on ART regimen 5A (tenofovir / lamivudine / efavirenz).

  • 80% of adults and 82% of children were retained alive on ART at 12 months after ART initiation.

  • A total of 11,452 HIV positive pregnant women were on ART: 4,343 (38%) of these were already on ART when getting pregnant and 7,109 (62%) started ART during pregnancy/delivery. This is equivalent to 73% ART coverage among the estimated 15,750 HIV infected pregnant women in Malawi this quarter. 6,910 (97%) of pregnant women started ART due to Option B+ (in WHO clinical stage 1 or 2) and 199 (3%) due to a low CD4 count and/or WHO clinical stage 3 or 4.

  • An additional 2,164 breastfeeding women started ART due to Option B+ (in WHO clinical stage 1 or 2).

  • 5,941 (77%) of 7,709 women started under Option B+ were retained at 6 months after ART initiation; 5,778 (76%) of 7569 were retained at 12 months after ART initiation.

  • 7,520 (7%) of infants discharged alive from maternity were known to be HIV exposed, 7,005 (93%) of these received ARV prophylaxis (nevirapine). 5,026 (67%) were enrolled in exposed child follow-up before age 2 months.

  • A total of 10,277 HIV exposed children and 9,886 pre-ART patients were enrolled for followup in HIV Care Clinics (HCC) during this quarter.

  • 112 medical staff were newly trained and certified in PMTCT/ART this quarter. This brings the total number trained in the 2011 guidelines to 5,823.

  • About 300 staff (mainly HSAs) at 52 facilities received mentoring for collection of dried blood samples for Early Infant Diagnosis and documentation of results.

  • 2,533 HTC providers were re-trained using the HTC Skills Intensive Training curriculum.

  • A total of 61 staff at 46 sites in 4 districts received clinical mentoring during a total of 90 mentoring visits (mentoring program reports remained incomplete for this quarter).

Data and Resources

Additional Info

Field Value
Program Area Care and Treatment
Year 2013
Author
Author Email